Protara (TARA) Stock Skyrockets After Promising Trial Results
Fahim Awan
December 5, 2024
After Protara Therapeutics, Inc. (NASDAQ: TARA) revealed encouraging results from its current Phase 2 ADVANCED-2 study, its shares jumped sharply, increasing more than 103% to